1. Home
  2. INTS vs SOS Comparison

INTS vs SOS Comparison

Compare INTS & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • SOS
  • Stock Information
  • Founded
  • INTS 2012
  • SOS 2004
  • Country
  • INTS United States
  • SOS China
  • Employees
  • INTS N/A
  • SOS N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • SOS Finance: Consumer Services
  • Sector
  • INTS Health Care
  • SOS Finance
  • Exchange
  • INTS Nasdaq
  • SOS Nasdaq
  • Market Cap
  • INTS 10.9M
  • SOS 10.7M
  • IPO Year
  • INTS 2023
  • SOS 2017
  • Fundamental
  • Price
  • INTS $0.23
  • SOS $1.84
  • Analyst Decision
  • INTS Strong Buy
  • SOS
  • Analyst Count
  • INTS 4
  • SOS 0
  • Target Price
  • INTS $4.50
  • SOS N/A
  • AVG Volume (30 Days)
  • INTS 4.0M
  • SOS 1.6M
  • Earning Date
  • INTS 11-12-2025
  • SOS 09-24-2025
  • Dividend Yield
  • INTS N/A
  • SOS N/A
  • EPS Growth
  • INTS N/A
  • SOS N/A
  • EPS
  • INTS N/A
  • SOS N/A
  • Revenue
  • INTS N/A
  • SOS $231,424,000.00
  • Revenue This Year
  • INTS N/A
  • SOS N/A
  • Revenue Next Year
  • INTS N/A
  • SOS N/A
  • P/E Ratio
  • INTS N/A
  • SOS N/A
  • Revenue Growth
  • INTS N/A
  • SOS 150.42
  • 52 Week Low
  • INTS $0.19
  • SOS $1.18
  • 52 Week High
  • INTS $4.30
  • SOS $2.04
  • Technical
  • Relative Strength Index (RSI)
  • INTS 32.86
  • SOS 42.85
  • Support Level
  • INTS $0.27
  • SOS $1.02
  • Resistance Level
  • INTS $0.30
  • SOS $2.04
  • Average True Range (ATR)
  • INTS 0.02
  • SOS 0.28
  • MACD
  • INTS -0.00
  • SOS 0.20
  • Stochastic Oscillator
  • INTS 6.39
  • SOS 79.90

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

Share on Social Networks: